Xiaojian Huang

2.5k total citations
44 papers, 2.1k citations indexed

About

Xiaojian Huang is a scholar working on Rheumatology, Molecular Biology and Pharmacology. According to data from OpenAlex, Xiaojian Huang has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 20 papers in Molecular Biology and 13 papers in Pharmacology. Recurrent topics in Xiaojian Huang's work include Osteoarthritis Treatment and Mechanisms (21 papers), Inflammatory mediators and NSAID effects (12 papers) and Natural product bioactivities and synthesis (8 papers). Xiaojian Huang is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (21 papers), Inflammatory mediators and NSAID effects (12 papers) and Natural product bioactivities and synthesis (8 papers). Xiaojian Huang collaborates with scholars based in China, United States and United Kingdom. Xiaojian Huang's co-authors include Timothy A. Stewart, Bruce D. Hultgren, Hongbo You, Noël Dybdal, Ling Fu, Mark Renz, Dorothy French, Lyn Powell-Braxton, Linu M. John and Elizabeth Tomlinson and has published in prestigious journals such as Science, Immunity and Diabetes Care.

In The Last Decade

Xiaojian Huang

43 papers receiving 2.0k citations

Peers

Xiaojian Huang
Comparison fields: 5 of 95
  • Molecular Biology 797
  • Genetics 633
  • Immunology 581
  • Surgery 487
  • Rheumatology 374
Replace Makiko Maeda with:
Makiko Maeda Japan
Hueng-Sik Choi South Korea
Marcia Meseck United States
Györgyi Műzes Hungary
Silvia Speca France
Chongren Tang United States
Florence Emmanuel France
Frédéric Van Gool Belgium
Philip N. Howles United States
Sunshin Kim South Korea
Makiko Maeda Japan View profile →
Citations per field, relative to Xiaojian Huang
Xiaojian Huang · 1×
Citations per year, relative to Xiaojian Huang
Xiaojian Huang · 1×

Countries citing papers authored by Xiaojian Huang

Since Specialization
Citations

This map shows the geographic impact of Xiaojian Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Huang more than expected).

Fields of papers citing papers by Xiaojian Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Huang. The network helps show where Xiaojian Huang may publish in the future.

Co-authorship network of co-authors of Xiaojian Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Huang. A scholar is included among the top collaborators of Xiaojian Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Huang. Xiaojian Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 4
3 9
4 10
5 22
6 26
7 24
8 16
9 12
10 43
11
Biophysical Characterization of Antibody Biopolymer Conjugate (ABC) Platform for Improved Therapy of Retinal Vascular Diseases
0
12 14
13
Development of Novel Bispecific Anti-Inflammatory and Anti-Angiogenic Therapy for the Treatment of both Retinal Vascular and Inflammatory Diseases
1
14 42
15
Chronic Nonclinical Ocular Toxicity Study of KSI-301 Demonstrates Tolerability after Intravitreal Administration in Cynomolgus Monkeys
1
16 40
17 6
18 58
19
KSI-301: An anti-VEGF antibody biopolymer conjugate with extended half-life for treatment of neovascular retinal diseases
10
20 41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026